Provider Perspectives of Conversations and Practices Surrounding Perinatal Cannabis Use

Recent research explored how perinatal healthcare providers approach conversations about substance use during pregnancy and the postpartum period. Although the study was conducted in the United States, many of the findings are applicable in Canada. The research highlights that conversations about substance use in pregnancy are widely viewed as important, but professionals may face challenges initiating or navigating these discussions. These insights reinforce the value of supportive, informed conversations, an approach that aligns closely with the goals of the FASD Prevention Conversation program.

Key Takeaways for Prevention Conversation Facilitators

  • Conversations are recognized as important. Providers see discussions about substance use during pregnancy as a routine and necessary part of supporting healthy outcomes. 
  • Comfort and confidence vary. Many professionals report feeling uncertain or uncomfortable discussing substance use, highlighting the need for practical tools and training. 
  • Screening does not always lead to meaningful dialogue. Even when providers ask about substance use, deeper conversations or referrals may not follow, suggesting an opportunity to strengthen supportive discussion skills. 
  • Trust and accurate information matter. Misconceptions about substances and uncertainty about risks highlight the importance of respectful, evidence-informed conversations that support informed decision-making.